Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by Smiles62on Jul 12, 2021 1:51pm
160 Views
Post# 33530361

RE:Blinkie Is Wrong!

RE:Blinkie Is Wrong!
beenthere wrote: Blinkie is wrong with his hard numbers but IMO this is very very hard to figure out so you cannot blame him.

I am going to throw out some numbers which may help but I know they are still wrong but closer than Blinkie!! lol

First of all the new raise back on March 22 news release talks about 85,294,117 SUBSCRIPTION RECEIPTS. These are NOT shares BUT they can be used to buy shares of the NEW company.

ICO HAS 181,292,213 shares

Satellos shareholders will receive 30.11 ICO shsares for each of theirs.

I DO NOT KNOW HOW MANY SATELLOS SHARES THERE ARE OUTSTANDING!!
BUT in the news release of March 22 they  mention 66.7% represents 8,138,400
SO 100% of Satellos would be 12,201,500

SO using that number WITHOUT KNOWING FOR SURE IT'S CORRECT
Satellos will get 367,387,165 ICO shares

SO the ICO shares 181,292,713 and the Satolles shares 367,387,165 together equal 548,679,878 total.

With the reverse split of 1 for 20 this becomes 27,433,994 shares.

This is the new company total shares  27,433,994
ICO will get 27.7 % or 7,599,216 shares.
Satellos will get 57.1%  or 15,664,810 shares

That leaves 15.2% or 4,169,968 which goes where??
I assume those that hold those "subscription receipts" will take them??
But for it to be even close the subscription receipts would have to do a 1 for 20 too.
I don't know that.

I hope (expect)  the actual necessary numbers of all of this will be provided by the companies!!

But for those who are still lost don't feel too bad.
But I will leave you with this!

Satellos is getting better than TWICE the common shares as ICO
AND you are going to take a major hit of a 1 for 20 REVERSE SPLIT
AND then only get 27.7% of the new company!

How many times do you have to be SCREWED OVER before you see this!!!!!!!

But like most sh*t like this you cannot stop it because Management already has the numbers!

Rubberband you are an idiot!





Beenthere, you are correct, there is absolutely nothing we can do, when a company announces a RS it's always calculated, so there is no way that retailers can stop their plan.
<< Previous
Bullboard Posts
Next >>